ANI Pharmaceuticals ANIP Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's non-cash lease expense?
- ANI Pharmaceuticals (ANIP) reported non-cash lease expense of $453K in Q1 2026.
- How has ANI Pharmaceuticals's non-cash lease expense changed year-over-year?
- ANI Pharmaceuticals's non-cash lease expense increased by 0.2% year-over-year, from $452K to $453K.
- What does non-cash lease expense mean?
- Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.